Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Operated Male to Female Sexual Function Index (oMtFSFI): A Study on the Validity of the First Questionnaire Developed to Assess the Sexual Function after Male to Female Gender Affirming Surgery.

Vedovo F, Di Blas L, Perin C, Pavan N, Zatta M, Bucci S, Morelli G, Cocci A, Delle Rose A, Grisanti SC, Gentile G, Colombo F, Rolle L, Timpano M, Verze P, Spirito L, Schiralli F, Bettocchi C, Garaffa G, Palmieri A, Mirone V, Trombetta C.

J Urol. 2020 Jan 31:101097JU0000000000000791. doi: 10.1097/JU.0000000000000791. [Epub ahead of print]

PMID:
32003598
2.

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion.

Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS.

Retina. 2020 Feb;40(2):303-311. doi: 10.1097/IAE.0000000000002394.

PMID:
31972801
3.

Corneal Allograft Treatment for Conjunctival Erosion Caused by Electronic Retinal Implant.

Rommel F, Grisanti S.

JAMA Ophthalmol. 2020 Jan 1;138(1):e190051. doi: 10.1001/jamaophthalmol.2019.0051. Epub 2020 Jan 9. No abstract available.

PMID:
31917433
4.

Vessel Density in Glaucoma of Different Entities as Measured with Optical Coherence Tomography Angiography.

Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S.

Clin Ophthalmol. 2019 Dec 17;13:2527-2534. doi: 10.2147/OPTH.S230192. eCollection 2019.

5.

[Uveal melanoma : Early detection as the key to successful personalized medicine].

Grisanti S, Ranjbar M, Tura A, Heindl LM, Kakkassery V.

Ophthalmologe. 2019 Dec 9. doi: 10.1007/s00347-019-01001-8. [Epub ahead of print] Review. German.

PMID:
31820082
6.

[Ocular lymphoma : Precise diagnostics and classification as key for successful personalized treatment].

Kakkassery V, Jünemann AM, Bechrakis NE, Grisanti S, Ranjbar M, Zschoche M, Heindl LM.

Ophthalmologe. 2019 Dec 6. doi: 10.1007/s00347-019-01020-5. [Epub ahead of print] Review. German.

PMID:
31811368
7.

[Alternative treatment options for periorbital basal cell carcinoma].

Kakkassery V, Emmert S, Adamietz IA, Kovács G, Jünemann AM, Otte C, Zimbelmann M, Brosig A, Grisanti S, Heindl LM.

Ophthalmologe. 2020 Feb;117(2):113-123. doi: 10.1007/s00347-019-01021-4. Review. German.

PMID:
31811367
8.

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.

Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Laganà M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A.

Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.

PMID:
31639772
9.

Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors.

Grisanti S, Filice A, Basile V, Cosentini D, Rapa I, Albano D, Morandi A, Laganà M, Dalla Volta A, Bertagna F, Tiberio GMA, Volante M, Terzolo M, Versari A, Berruti A.

J Clin Endocrinol Metab. 2019 Oct 21. pii: dgz091. doi: 10.1210/clinem/dgz091. [Epub ahead of print]

PMID:
31633759
10.

Fluorescence Lifetime Imaging Ophthalmoscopy of the Retinal Pigment Epithelium During Wound Healing After Laser Irradiation.

Hutfilz A, Sonntag SR, Lewke B, Theisen-Kunde D, Grisanti S, Brinkmann R, Miura Y.

Transl Vis Sci Technol. 2019 Sep 18;8(5):12. doi: 10.1167/tvst.8.5.12. eCollection 2019 Sep.

11.

Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma.

Consoli F, Bersanelli M, Perego G, Grisanti S, Merelli B, Berruti A, Petrelli F.

Clin Transl Oncol. 2019 Sep 25. doi: 10.1007/s12094-019-02207-7. [Epub ahead of print] Review.

PMID:
31555967
12.

In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures.

Fragni M, Palma Lopez LP, Rossini E, Abate A, Cosentini D, Salvi V, Vezzoli S, Poliani PL, Bosisio D, Hantel C, Tiberio GAM, Grisanti S, Memo M, Terzolo M, Berruti A, Sigala S.

Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16.

PMID:
31536779
13.

Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study.

Ranjbar M, Rothe M, Klapa S, Lange T, Prasuhn M, Grisanti S, Riemekasten G, Humrich JY.

Scand J Rheumatol. 2019 Sep 17:1-5. doi: 10.1080/03009742.2019.1641616. [Epub ahead of print]

PMID:
31526060
14.

Antineoplastic activity of artemisinin in adrenocortical carcinoma.

Lorini L, Grisanti S, Ambrosini R, Cosentini D, Laganà M, Grazioli L, Tiberio GAM, Sigala S, Berruti A.

Endocrine. 2019 Nov;66(2):425-427. doi: 10.1007/s12020-019-02077-7. Epub 2019 Sep 6. No abstract available.

PMID:
31493273
15.

Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities.

Tura A, Pawlik VE, Rudolf M, Ernesti JS, Stutzer JN, Grisanti S, Ranjbar M.

Cancers (Basel). 2019 Jun 21;11(6). pii: E868. doi: 10.3390/cancers11060868.

16.

One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study.

Schaffrath K, Schellhase H, Walter P, Augustin A, Chizzolini M, Kirchhof B, Grisanti S, Wiedemann P, Szurman P, Richard G, Greenberg RJ, Dorn JD, Parmeggiani F, Rizzo S.

JAMA Ophthalmol. 2019 May 30. doi: 10.1001/jamaophthalmol.2019.1476. [Epub ahead of print]

PMID:
31145440
17.

Mapping diurnal variations in choroidal sublayer perfusion in patients with idiopathic epiretinal membrane: an optical coherence tomography angiography study.

Rommel F, Siegfried F, Sochurek JAM, Rothe M, Brinkmann MP, Kurz M, Prasuhn M, Grisanti S, Ranjbar M.

Int J Retina Vitreous. 2019 May 21;5:12. doi: 10.1186/s40942-019-0162-2. eCollection 2019.

18.

Evaluating diurnal changes in choroidal sublayer perfusion using optical coherence tomography angiography.

Siegfried F, Rommel F, Rothe M, Brinkmann MP, Sochurek JAM, Freitag J, Grisanti S, Ranjbar M.

Acta Ophthalmol. 2019 Dec;97(8):e1062-e1068. doi: 10.1111/aos.14140. Epub 2019 May 14.

PMID:
31087516
19.

Retinal perfusion 6 months after trabeculectomy as measured by optical coherence tomography angiography.

Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S.

Int Ophthalmol. 2019 Nov;39(11):2583-2594. doi: 10.1007/s10792-019-01107-7. Epub 2019 May 9.

PMID:
31073739
20.

Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma.

Fiorentini C, Grisanti S, Cosentini D, Abate A, Rossini E, Berruti A, Sigala S.

J Oncol. 2019 Apr 1;2019:6072863. doi: 10.1155/2019/6072863. eCollection 2019. Review.

21.

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study.

Berruti A, Libè R, Laganà M, Ettaieb H, Sukkari MA, Bertherat J, Feelders RA, Grisanti S, Cartry J, Mazziotti G, Sigala S, Baudin E, Haak H, Habra MA, Terzolo M.

Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026.

PMID:
30970324
22.

Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy.

Consoli F, Manganoni AM, Grisanti S, Petrelli F, Venturini M, Rangoni G, Guarneri F, Incardona P, Vermi W, Calzavara Pinton PG, Berruti A.

PLoS One. 2019 Apr 2;14(4):e0214884. doi: 10.1371/journal.pone.0214884. eCollection 2019.

23.

Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients.

Ranjbar M, Prasuhn M, Kurz M, Holzhey A, Rommel F, Brinkmann MP, Rades D, Grisanti S.

J Curr Ophthalmol. 2019 Jan 2;31(1):92-94. doi: 10.1016/j.joco.2018.12.004. eCollection 2019 Mar.

24.

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events.

Grisanti S, Bianchi S, Locati LD, Triggiani L, Vecchio S, Bonetta A, Bergamini C, Conte P, Airoldi M, Merlano M, Carlini P, Ibrahim T, Rossetto C, Alfieri S, Pronzato P, Tonoli S, Maroldi R, Nicolai P, Resteghini C, Magrini SM, Berruti A.

PLoS One. 2019 Mar 20;14(3):e0213934. doi: 10.1371/journal.pone.0213934. eCollection 2019.

25.

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.

Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Cabel L, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Generali D, Cappelletti MR, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Darrigues L, Reis-Filho JS, Gerratana L, Michiels S, Bidard FC, Pantel K.

Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19. Review.

PMID:
30771872
26.

Apolipoprotein A-I Mimetic Peptide L-4F Removes Bruch's Membrane Lipids in Aged Nonhuman Primates.

Rudolf M, Curcio CA, Schlötzer-Schrehardt U, Sefat AMM, Tura A, Aherrahrou Z, Brinkmann M, Grisanti S, Miura Y, Ranjbar M.

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):461-472. doi: 10.1167/iovs.18-25786. Erratum in: Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1009.

PMID:
30707219
27.

Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes.

Grisanti S, Grisanti S, Garcia-Feijoo J, Dick HB, Munoz-Negrete FJ, Arrondo E, Ianchulev T.

BMJ Open Ophthalmol. 2018 Dec 22;3(1):e000183. doi: 10.1136/bmjophth-2018-000183. eCollection 2018.

28.

[New molecular pathological strategies for malignant iris tumors].

Kakkassery V, Jünemann AM, Scheef BO, Grisanti S, Heindl LM.

Ophthalmologe. 2019 Apr;116(4):324-331. doi: 10.1007/s00347-018-0840-8. Review. German.

PMID:
30623224
29.

Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study.

Rothe M, Rommel F, Klapa S, Humrich JY, Nieberding R, Lange T, Sochurek JAM, Plöttner P, Grisanti S, Riemekasten G, Ranjbar M.

Ann Rheum Dis. 2019 Jun;78(6):857-858. doi: 10.1136/annrheumdis-2018-214541. Epub 2019 Jan 3. No abstract available.

PMID:
30606740
30.

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion.

Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS.

Retina. 2018 Nov 20. doi: 10.1097/IAE.0000000000002394. [Epub ahead of print]

PMID:
30475288
31.

Immunotherapy failure in adrenocortical cancer: where next?

Cosentini D, Grisanti S, Dalla Volta A, Laganà M, Fiorentini C, Perotti P, Sigala S, Berruti A.

Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398.

32.

In vitro antitumor activity of progesterone in human adrenocortical carcinoma.

Fragni M, Fiorentini C, Rossini E, Fisogni S, Vezzoli S, Bonini SA, Dalmiglio C, Grisanti S, Tiberio GAM, Claps M, Cosentini D, Salvi V, Bosisio D, Terzolo M, Missale C, Facchetti F, Memo M, Berruti A, Sigala S.

Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26.

33.

Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study.

Abdullatif AM, Macky TA, Abdullatif MM, Nassar K, Grisanti S, Mortada HA, Soliman MM.

Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2473-2481. doi: 10.1007/s00417-018-4105-7. Epub 2018 Aug 20.

PMID:
30128605
34.

Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.

Pedersini R, Vassalli L, Claps M, Tulla A, Rodella F, Grisanti S, Amoroso V, Roca E, Simoncini EL, Berruti A.

Oncology. 2018;94 Suppl 1:10-15. doi: 10.1159/000489063. Epub 2018 Jul 23.

35.

Impact of correct anatomical slab segmentation on foveal avascular zone measurements by optical coherence tomography angiography in healthy adults.

Rommel F, Siegfried F, Kurz M, Brinkmann MP, Rothe M, Rudolf M, Grisanti S, Ranjbar M.

J Curr Ophthalmol. 2018 Mar 20;30(2):156-160. doi: 10.1016/j.joco.2018.02.001. eCollection 2018 Jun.

36.

Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study.

Gregori NZ, Callaway NF, Hoeppner C, Yuan A, Rachitskaya A, Feuer W, Ameri H, Arevalo JF, Augustin AJ, Birch DG, Dagnelie G, Grisanti S, Davis JL, Hahn P, Handa JT, Ho AC, Huang SS, Humayun MS, Iezzi R Jr, Jayasundera KT, Kokame GT, Lam BL, Lim JI, Mandava N, Montezuma SR, Olmos de Koo L, Szurman P, Vajzovic L, Wiedemann P, Weiland J, Yan J, Zacks DN.

Am J Ophthalmol. 2018 Sep;193:87-99. doi: 10.1016/j.ajo.2018.06.012. Epub 2018 Jun 27.

37.

Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration.

Isella V, Grisanti SG, Ferri F, Morzenti S, Crivellaro C, Musarra M, Ferrarese C.

Eur J Neurol. 2018 Nov;25(11):1333-1340. doi: 10.1111/ene.13729. Epub 2018 Jul 21.

PMID:
29931723
38.

Uveal Melanoma.

Grisanti S, Tura A.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 1.

39.

Liquid Biopsy for Uveal Melanoma.

Tura A, Lueke J, Grisanti S.

In: Scott JF, Gerstenblith MR, editors. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Chapter 3.

40.

Vessel density in OCT angiography permits differentiation between normal and glaucomatous optic nerve heads.

Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S.

Int J Ophthalmol. 2018 May 18;11(5):835-843. doi: 10.18240/ijo.2018.05.20. eCollection 2018.

41.

Subfoveal Choroidal Thickness as a Potential Predictor of Clinical Response to Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration.

Ranjbar M, Kurz M, Holzhey A, Rades D, Grisanti S.

Ophthalmic Surg Lasers Imaging Retina. 2018 May 1;49(5):320-328. doi: 10.3928/23258160-20180501-05.

PMID:
29772042
42.

OCTA vessel density changes in the macular zone in glaucomatous eyes.

Lommatzsch C, Rothaus K, Koch JM, Heinz C, Grisanti S.

Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1499-1508. doi: 10.1007/s00417-018-3965-1. Epub 2018 Apr 10.

PMID:
29637255
43.

Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma.

Grisanti S, Cosentini D, Tovazzi V, Bianchi S, Lazzari B, Consoli F, Roca E, Berruti A, Ferrari VD.

Support Care Cancer. 2018 Aug;26(8):2929-2935. doi: 10.1007/s00520-018-4129-x. Epub 2018 Mar 15.

PMID:
29546526
44.

Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review.

Antonelli A, Palumbo C, Veccia A, Grisanti S, Triggiani L, Zamboni S, Furlan M, Simeone C, Magrini S, Berruti A.

Minerva Urol Nefrol. 2018 Aug;70(4):370-379. doi: 10.23736/S0393-2249.18.03022-9. Epub 2018 Feb 1. Review.

45.

[RPE morphometry in geographic atrophy due to AMD].

Wagner A, Mohi A, Ranjbar M, Grisanti S, Rudolf M.

Ophthalmologe. 2019 Jan;116(1):43-50. doi: 10.1007/s00347-017-0638-0. German.

PMID:
29313132
46.

Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.

Claps M, Cerri S, Grisanti S, Lazzari B, Ferrari V, Roca E, Perotti P, Terzolo M, Sigala S, Berruti A.

Endocrine. 2018 Jul;61(1):169-172. doi: 10.1007/s12020-017-1428-9. Epub 2017 Oct 10. No abstract available.

47.

ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling.

Rudolf M, Mir Mohi Sefat A, Miura Y, Tura A, Raasch W, Ranjbar M, Grisanti S, Aherrahrou Z, Wagner A, Messinger JD, Garber DW, Anantharamaiah GM, Curcio CA.

Curr Eye Res. 2018 Jan;43(1):135-146. doi: 10.1080/02713683.2017.1370118. Epub 2017 Oct 3.

PMID:
28972410
48.

Changes in Peripapillary Nerve Fiber Layer Thickness after Adjuvant Stereotactic Radiotherapy in Patients with Neovascular Age-Related Macular Degeneration.

Ranjbar M, Kurz M, Holzhey A, Rades D, Grisanti S.

Curr Eye Res. 2017 Dec;42(12):1698-1706. doi: 10.1080/02713683.2017.1355972. Epub 2017 Sep 22.

PMID:
28937877
49.

[Patient-Reported Treatment Satisfaction with Stereotactic Radiotherapy in Neovascular Age-Related Macular Degeneration].

Kurz M, Rudolf M, Holzhey A, Neubauer AS, Grisanti S, Ranjbar M.

Klin Monbl Augenheilkd. 2019 Jul;236(7):892-900. doi: 10.1055/s-0043-115903. Epub 2017 Aug 24. German.

PMID:
28837976
50.

[Current Diagnosis of Choroidal Nevi].

Lüke J, Grisanti S, Tura A.

Klin Monbl Augenheilkd. 2018 Jun;235(6):730-739. doi: 10.1055/s-0043-102592. Epub 2017 Jun 9. Review. German.

PMID:
28599335

Supplemental Content

Loading ...
Support Center